A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines

Virus Research

Volumn 167, Issue 2, 2012, Pages 179-187

  Saxena, Vandana ^a   Welte, Thomas ^a   Bao, Xiaoyong ^a   Xie, Guorui ^a   Wang, Jia ^a   Higgs, Stephen ^b   Tesh, Robert B ^a,c   Wang, Tian ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Pathogenesis; Persistence; Proinflammatory cytokines; West Nile virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; FLAVIVIRUS INFECTION; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; KIDNEY EPITHELIUM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS ATTENUATION; VIRUS LOAD; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION;

ANIMALS; CELL LINE; CRICETINAE; CYTOKINES; EPITHELIAL CELLS; MACROPHAGES; MICE; NF-KAPPA B; URINE; VIRULENCE; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; CRICETINAE; MURINAE; WEST NILE VIRUS;

EID: 84863870131     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.04.013     Document Type: Article

References (52)

1. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunology Letters 2003, 85(2):85-95.
2. Appler K.K., Brown A.N., Stewart B.S., Behr M.J., Demarest V.L., Wong S.J., Bernard K.A. Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 2010, 5(5):e10649.
3. Beasley D.W., Li L., Suderman M.T., Barrett A.D. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296(1):17-23.
4. Brien J.D., Uhrlaub J.L., Nikolich-Zugich J. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. European Journal of Immunology 2007, 37(7):1855-1863.
5. Busch M.P., Kleinman S.H., Tobler L.H., Kamel H.T., Norris P.J., Walsh I., Matud J.L., Prince H.E., Lanciotti R.S., Wright D.J., Linnen J.M., Caglioti S. Virus and antibody dynamics in acute west nile virus infection. Journal of Infectious Diseases 2008, 198(7):984-993.
6. Campbell G.L., Marfin A.A., Lanciotti R.S., Gubler D.J. West Nile virus. Lancet Infectious Diseases 2002, 2(9):519-529.
7. Cardosa M.J., Porterfield J.S., Gordon S. Complement receptor mediates enhanced flavivirus replication in macrophages. Journal of Experimental Medicine 1983, 158(1):258-263.
8. Carson P.J., Konewko P., Wold K.S., Mariani P., Goli S., Bergloff P., Crosby R.D. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clinical Infectious Diseases 2006, 43(6):723-730.
9. Conti L., Casetti R., Cardone M., Varano B., Martino A., Belardelli F., Poccia F., Gessani S. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. Journal of Immunology 2005, 174(1):252-260.
10. Cook R.L., Xu X., Yablonsky E.J., Sakata N., Tripp J.H., Hess R., Piazza P., Rinaldo C.R. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. American Journal of Tropical Medicine and Hygiene 2010, 83(5):1133-1136.
11. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., Bowen R., Bunning M.L. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. Journal of Virology 2001, 75(9):4040-4047.
12. Diamond M.S., Shrestha B., Marri A., Mahan D., Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. Journal of Virology 2003, 77(4):2578-2586.
13. Diamond M.S., Shrestha B., Mehlhop E., Sitati E., Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunology 2003, 16(3):259-278.
14. Diamond M.S., Sitati E.M., Friend L.D., Higgs S., Shrestha B., Engle M. A critical role for induced IgM in the protection against West Nile virus infection. Journal of Experimental Medicine 2003, 198(12):1853-1862.
15. Dieli F., Caccamo N., Meraviglia S., Ivanyi J., Sireci G., Bonanno C.T., Ferlazzo V., La Mendola C., Salerno A. Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response. European Journal of Immunology 2004, 34(11):3227-3235.
16. Ding X., Wu X., Duan T., Siirin M., Guzman H., Yang Z., Tesh R.B., Xiao S.Y. Nucleotide and amino acid changes in West Nile virus strains exhibiting renal tropism in hamsters. American Journal of Tropical Medicine and Hygiene 2005, 73(4):803-807.
17. Fredericksen B.L., Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. Journal of Virology 2006, 80(6):2913-2923.
18. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. Journal of Virology 2008, 82(2):609-616.
19. Goodman W.A., Levine A.D., Massari J.V., Sugiyama H., McCormick T.S., Cooper K.D. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. Journal of Immunology 2009, 183(5):3170-3176.
20. Gubler D.J. The continuing spread of West Nile virus in the western hemisphere. Clinical Infectious Diseases 2007, 45(8):1039-1046.
21. Harker J.A., Lewis G.M., Mack L., Zuniga E.I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 2011, 334(6057):825-829.
22. Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. American Journal of Tropical Medicine and Hygiene 1982, 31(4):830-836.
23. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nature Immunology 2004, 5(10):987-995.
24. King N.J., Shrestha B., Kesson A.M. Immune modulation by flaviviruses. Advances in Virus Research 2003, 60:121-155.
25. Kramer L.D., Bernard K.A. West Nile virus infection in birds and mammals. Annals of the New York Academy of Sciences 2001, 951:84-93.
26. Kramer L.D., Styer L.M., Ebel G.D. A global perspective on the epidemiology of West Nile virus. Annual Review of Entomology 2008, 53:61-81.
27. Lanciotti R.S., Kerst A.J., Nasci R.S., Godsey M.S., Mitchell C.J., Savage H.M., Komar N., Panella N.A., Allen B.C., Volpe K.E., Davis B.S., Roehrig J.T. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. Journal of Clinical Microbiology 2000, 38(11):4066-4071.
28. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nature Reviews Immunology 2002, 2(10):725-734.
29. Moriyama M., Matsumura H., Nirei K., Arakawa Y., Yamagami H., Ogawa M., Kaneko M., Matsuoka S., Amaki S., Tanaka N. Factors influencing treatment efficacy of 24-week combination therapy with interferon alpha-2b plus ribavirin for chronic hepatitis C. Digestive Diseases and Sciences 2007, 52(9):2418-2426.
30. Murray K., Walker C., Herrington E., Lewis J.A., McCormick J., Beasley D.W., Tesh R.B., Fisher-Hoch S. Persistent infection with West Nile virus years after initial infection. Journal of Infectious Diseases 2010, 201(1):2-4.
31. Ou A.C., Ratard R.C. One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. Journal of the Louisiana State Medical Society 2005, 157(1):42-46.
32. Papa A., Danis K., Athanasiadou A., Delianidou M., Panagiotopoulos T. Persistence of West Nile virus immunoglobulin M antibodies, Greece. Journal of Medical Virology 2011, 83(10):1857-1860.
33. Penn R.G., Guarner J., Sejvar J.J., Hartman H., McComb R.D., Nevins D.L., Bhatnagar J., Zaki S.R. Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clinical Infectious Diseases 2006, 42(5):680-683.
34. Pletnev A.G., Swayne D.E., Speicher J., Rumyantsev A.A., Murphy B.R. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 2006, 24(40-41):6392-6404.
35. Pogodina V.V., Bochkova N.G., Levina L.S. Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response. Acta Virologica 1984, 28(5):407-415.
36. Pogodina V.V., Frolova M.P., Malenko G.V., Fokina G.I., Koreshkova G.V., Kiseleva L.L., Bochkova N.G., Ralph N.M. Study on West Nile virus persistence in monkeys. Archives of Virology 1983, 75(1-2):71-86.
37. Ratterree M.S., Gutierrez R.A., Travassos da Rosa A.P., Dille B.J., Beasley D.W., Bohm R.P., Desai S.M., Didier P.J., Bikenmeyer L.G., Dawson G.J., Leary T.P., Schochetman G., Phillippi-Falkenstein K., Arroyo J., Barrett A.D., Tesh R.B. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. Journal of Infectious Diseases 2004, 189(4):669-676.
38. Ravindra K.V., Freifeld A.G., Kalil A.C., Mercer D.F., Grant W.J., Botha J.F., Wrenshall L.E., Stevens R.B. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clinical Infectious Diseases 2004, 38(9):1257-1260.
39. Rios M., Zhang M.J., Grinev A., Srinivasan K., Daniel S., Wood O., Hewlett I.K., Dayton A.I. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 2006, 46(4):659-667.
40. Roehrig J.T., Staudinger L.A., Hunt A.R., Mathews J.H., Blair C.D. Antibody prophylaxis and therapy for flavivirus encephalitis infections. Annals of the New York Academy of Sciences 2001, 951:286-297.
41. Sadek J.R., Pergam S.A., Harrington J.A., Echevarria L.A., Davis L.E., Goade D., Harnar J., Nofchissey R.A., Sewell C.M., Ettestad P., Haaland K.Y. Persistent neuropsychological impairment associated with West Nile virus infection. Journal of Clinical and Experimental Neuropsychology 2010, 32(1):81-87.
42. Scholle F., Mason P.W. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 2005, 342(1):77-87.
43. Shrestha B., Diamond M.S. Role of CD8+ T cells in control of West Nile virus infection. Journal of Virology 2004, 78(15):8312-8321.
44. Siddharthan V., Wang H., Motter N.E., Hall J.O., Skinner R.D., Skirpstunas R.T., Morrey J.D. Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. Journal of Virology 2009, 83(9):4251-4261.
45. Sitati E.M., Diamond M.S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. Journal of Virology 2006, 80(24):12060-12069.
46. Tesh R.B., Siirin M., Guzman H., Travassos da Rosa A.P., Wu X., Duan T., Lei H., Nunes M.R., Xiao S.Y. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. Journal of Infectious Diseases 2005, 192(2):287-295.
47. Tesh R.B., Xiao S.Y. Persistence of West Nile virus infection in vertebrates. West Nile Encephalitis Virus Infection Viral Pathogenesis and Host Response 2009, 361-377. Springer, New York. M.S. Diamond (Ed.).
48. Tonry J.H., Xiao S.Y., Siirin M., Chen H., da Rosa A.P., Tesh R.B. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. American Journal of Tropical Medicine and Hygiene 2005, 72(3):320-324.
49. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Medicine 2004, 10(12):1366-1373.
50. Wilson J.R., de Sessions P.F., Leon M.A., Scholle F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. Journal of Virology 2008, 82(17):8262-8271.
51. Wu X., Lu L., Guzman H., Tesh R.B., Xiao S.Y. Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters. Journal of General Virology 2008, 89(Pt 12):3073-3079.
52. Xiao S.Y., Guzman H., Zhang H., Travassos da Rosa A.P., Tesh R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerging Infectious Diseases 2001, 7(4):714-721.